Advanced search
Publication Cover
Drug Development and Industrial Pharmacy Volume 39, 2013 - Issue 11
Submit an article Journal homepage
280
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Brain pharmacokinetics of neurotoxin-loaded PLA nanoparticles modified with chitosan after intranasal administration in awake rats

Xingguo Zhang
,
Lin LiuDepartment of Pharmacology, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
,
Guobao ChaiCollege of Pharmaceutical Science, ZheJiang Chinese Medical University, HangZhou, China
,
Xiangyi ZhangDepartment of Pharmacology, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
&
Fanzhu LiCollege of Pharmaceutical Science, ZheJiang Chinese Medical University, HangZhou, ChinaCorrespondence[email protected]
Pages 1618-1624 | Received 09 Sep 2011, Accepted 29 Aug 2012, Published online: 02 Oct 2013

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Monica R. P. Rao & Rohini C. Bhingole. (2015) Nanosponge-based pediatric-controlled release dry suspension of Gabapentin for reconstitution. Drug Development and Industrial Pharmacy 41:12, pages 2029-2036.
Read now

Articles from other publishers (13)

Lin Liu, Wendong Yao, Xiaowei Xie, Jianqing Gao & Xiaoyang Lu. (2021) pH-sensitive dual drug loaded janus nanoparticles by oral delivery for multimodal analgesia. Journal of Nanobiotechnology 19:1.
Crossref
Raju O. Sonawane, Yogeshwar Bachhav, Avinash R. Tekade & Chandrakantsing V. Pardeshi. 2021. Direct Nose-to-Brain Drug Delivery. Direct Nose-to-Brain Drug Delivery 157 168 .
Chandrakantsing V. Pardeshi & Eliana B. Souto. 2021. Direct Nose-to-Brain Drug Delivery. Direct Nose-to-Brain Drug Delivery 93 114 .
Hernán Cortés, Sergio Alcalá-Alcalá, Isaac H. Caballero-Florán, Sergio A. Bernal-Chávez, Arturo Ávalos-Fuentes, Maykel González-Torres, Manuel González-Del Carmen, Gabriela Figueroa-González, Octavio D. Reyes-Hernández, Benjamín Floran, María L. Del Prado-Audelo & Gerardo Leyva-Gómez. (2020) A Reevaluation of Chitosan-Decorated Nanoparticles to Cross the Blood-Brain Barrier. Membranes 10:9, pages 212.
Crossref
Namdev Dhas & Tejal Mehta. (2020) Cationic biopolymer functionalized nanoparticles encapsulating lutein to attenuate oxidative stress in effective treatment of Alzheimer’s disease: A non-invasive approach. International Journal of Pharmaceutics 586, pages 119553.
Crossref
Ana P. dos Santos, Tamara G. de Araújo & Gandhi Rádis-Baptista. (2020) Nanoparticles Functionalized with Venom-Derived Peptides and Toxins for Pharmaceutical Applications. Current Pharmaceutical Biotechnology 21:2, pages 97-109.
Crossref
Robert A Yokel. (2020) Nanoparticle brain delivery: a guide to verification methods. Nanomedicine 15:4, pages 409-432.
Crossref
Zui Zhang & Changyou Zhan. 2019. Brain Targeted Drug Delivery System. Brain Targeted Drug Delivery System 105 128 .
Imane Himri & Abdelkarim Guaadaoui. 2018. Nanostructures for the Engineering of Cells, Tissues and Organs. Nanostructures for the Engineering of Cells, Tissues and Organs 1 66 .
Rui Ma, Ravikiran Mahadevappa & Hang Fai Kwok. (2017) Venom-based peptide therapy: insights into anti-cancer mechanism. Oncotarget 8:59, pages 100908-100930.
Crossref
Dongfen Yuan, Xiang Yi, Yuling Zhao, Chi-Duen Poon, Kristin M. Bullock, Kim M. Hansen, Therese S. Salameh, Susan A. Farr, William A. Banks & Alexander V. Kabanov. (2017) Intranasal delivery of N-terminal modified leptin-pluronic conjugate for treatment of obesity. Journal of Controlled Release.
Crossref
Lindsey Crawford, Justin Rosch & David Putnam. (2016) Concepts, technologies, and practices for drug delivery past the blood–brain barrier to the central nervous system. Journal of Controlled Release 240, pages 251-266.
Crossref
Zhigui Su, Lei Xing, Yinan Chen, Yurui Xu, Feifei Yang, Can Zhang, Qineng Ping & Yanyu Xiao. (2014) Lactoferrin-Modified Poly(ethylene glycol)-Grafted BSA Nanoparticles as a Dual-Targeting Carrier for Treating Brain Gliomas. Molecular Pharmaceutics 11:6, pages 1823-1834.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.